文献速递疼痛医学术前评估与围术期医学

慢性疼痛患者阿片类药物问题使用风险评估工具的系统综述

Systematic review to determine which validated measurement tools can be used to assess risk of problematic analgesic use in patients with chronic pain.
PubMed 文献 · Br J Anaesth · 2017-01-01

该系统综述检索多个数据库,评估慢性非癌性疼痛患者阿片类药物滥用风险评估与监测工具,共纳入30项研究、覆盖14种工具。结果显示,预测处方阿片类药物滥用以PMQ和SOAPP证据最佳,筛查当前滥用以COMM表现最佳;非阿片类镇痛药尚无可用工具。

要点

  • PMQ和SOAPP预测处方阿片类药物滥用证据最佳。
  • COMM筛查当前阿片类药物滥用表现最佳。
  • 非阿片类镇痛药缺乏风险评估工具。

核心结论

  • 少数工具可较准确预测或识别阿片类药物滥用,但非阿片类镇痛药领域尚无工具。

研究设计与样本

  • 系统综述,检索Embase、Medline、Cochrane library/CENTRAL、PsycINFO、PubMed、CINAHL等数据库,最终纳入30项研究(含3项系统综述),另从参考文献补充4项研究。

主要发现

  • 纳入研究覆盖14种与阿片类药物使用相关的工具,无针对非阿片类镇痛药的工具。
  • PMQ和SOAPP预测处方阿片类药物滥用证据最佳,各在5项独立研究中开发与验证(各4项质量可接受)。
  • COMM筛查当前阿片类药物滥用表现最佳,在3项质量可接受的研究中开发与验证。

临床怎么用

  • 慢性疼痛患者启动或维持阿片类药物治疗时,可优先选用PMQ或SOAPP评估滥用风险,用COMM筛查当前滥用。

局限性

  • 非阿片类镇痛药风险评估工具缺乏,存在潜在需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Misuse of prescription opioids, and other drugs prescribed for chronic pain, has increased, with major concerns about harm. This review was undertaken to identify validated measurement tools for risk assessment and monitoring of chronic non-cancer pain patients being considered for, or currently prescribed, analgesic drugs with abuse potential. METHODS: Selected databases (Embase, Medline, Cochrane library/CENTRAL, PsycINFO, PubMed, CINAHL) were systematically searched for studies evaluating tools for risk of analgesic misuse, either before, or during, analgesic therapy for chronic pain, using predetermined inclusion/exclusion criteria. Two independent reviewers assessed abstracts, selected full texts, extracted data and assessed quality. RESULTS: 30 studies from 1844 met inclusion criteria, including three systematic reviews, with an additional four studies from bibliography review. The studies covered 14 tools pertaining to opioid use, with none for non-opioid analgesics. CONCLUSIONS: For predicting prescription opioid misuse, the pain medication questionnaire (PMQ) and the screener and opioid assessment for patients with pain (SOAPP) had the best evidence; both developed and validated in five separate studies (four each of acceptable quality). The current opioid misuse measure (COMM) performed best screening for current misuse, developed and validated in three studies of acceptable quality. A small number of tools may accurately predict, or identify, opioid misuse. There are none for non-opioid analgesics, where there is a potential need.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Lawrence R, Mogford D, Colvin L, et al. Systematic review to determine which validated measurement tools can be used to assess risk of problematic analgesic use in patients with chronic pain. Br J Anaesth. 2017. PMID: 28981581. doi:10.1093/bja/aex316

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。